These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24128974)

  • 1. Adiponectin: an attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD).
    Bianco A; Mazzarella G; Turchiarelli V; Nigro E; Corbi G; Scudiero O; Sofia M; Daniele A
    Nutrients; 2013 Oct; 5(10):4115-25. PubMed ID: 24128974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
    Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
    Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD.
    Leivo-Korpela S; Lehtimäki L; Vuolteenaho K; Nieminen R; Kööbi L; Järvenpää R; Kankaanranta H; Saarelainen S; Moilanen E
    Respir Med; 2014 Jan; 108(1):122-8. PubMed ID: 24135487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipokine CTRP-5 as a Potential Novel Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease.
    Li D; Wu Y; Tian P; Zhang X; Wang H; Wang T; Ying B; Wang L; Shen Y; Wen F
    Medicine (Baltimore); 2015 Sep; 94(36):e1503. PubMed ID: 26356719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression.
    Oh YM; Jeong BH; Woo SY; Kim SY; Kim H; Lee JH; Lim SY; Rhee CK; Yoo KH; Lee JH; Yoon HK; Sin DD; Lee SD; Kim EK; Park HY;
    Ann Am Thorac Soc; 2015 Jul; 12(7):1005-12. PubMed ID: 26010877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin.
    Yoon HI; Li Y; Man SFP; Tashkin D; Wise RA; Connett JE; Anthonisen NA; Churg A; Wright JL; Sin DD
    Chest; 2012 Oct; 142(4):893-899. PubMed ID: 22207678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
    Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
    Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serum levels of adiponectin and leptin in mustard lung patients.
    Rokni Yazdi H; Lari SM; Attaran D; Ayatollahi H; Mohsenizadeh A
    Hum Exp Toxicol; 2014 Jun; 33(6):574-81. PubMed ID: 24064910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.
    MacNee W
    Ann Med; 2013 May; 45(3):291-300. PubMed ID: 23110517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, adipokines, and lung disease.
    Sood A
    J Appl Physiol (1985); 2010 Mar; 108(3):744-53. PubMed ID: 19926824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulatory and adipose tissue leptin and adiponectin in relationship to resting energy expenditure in patients with chronic obstructive pulmonary disease.
    Brúsik M; Ukropec J; Joppa P; Ukropcová B; Skyba P; Baláž M; Pobeha P; Kurdiová T; Klimeš I; Tkáč I; Gašperíková D; Tkáčová R
    Physiol Res; 2012; 61(5):469-80. PubMed ID: 22881231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
    Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
    Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin in inflammatory and immune-mediated diseases.
    Fantuzzi G
    Cytokine; 2013 Oct; 64(1):1-10. PubMed ID: 23850004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of plasma adiponectin levels with cellular hydration state measured using bioelectrical impedance analysis in patients with COPD.
    Yoshikawa T; Kanazawa H
    Int J Chron Obstruct Pulmon Dis; 2012; 7():515-21. PubMed ID: 22927754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities.
    Minas M; Kostikas K; Papaioannou AI; Mystridou P; Karetsi E; Georgoulias P; Liakos N; Pournaras S; Gourgoulianis KI
    COPD; 2011 Dec; 8(6):414-20. PubMed ID: 22149401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
    Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F
    Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
    Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low FEV1 Is Associated With Increased Risk Of Cachexia In COPD Patients.
    Mokari-Yamchi A; Jabbari M; Sharifi A; Barati M; Kheirouri S
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2433-2440. PubMed ID: 31802861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.